Research and Markets (http://www.researchandmarkets.com/research/b9lrqd/a_product_and) has announced the addition of the "A Product and Pipeline Analysis of the Antibacterial Drugs Market " report to their offering.
Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies.
This research service focuses on the global antibacterial drugs (antibiotics) market, with particular focus on the antibiotics currently under development. A list of currently available and marketed antibacterial drugs under the approved antibacterial drug classes has been provided. Product and pipeline assessment for recently approved antibacterial drugs, antibacterials under FDA review, as well as phase 3 antibacterial drug candidates have been provided. A detailed overview of the various regulatory approaches to foster innovation in the development of new antibiotics has been provided as well.
Antibacterial Drugs Listed
- Tedizolid Phosphate-Cubist Pharmaceuticals
- Dalbavancin (Dalvance)-Durata Therapeutics
- Ceftolozane + Tazobactam-Cubist Pharmaceuticals
- Oritavancin (Orbactiv)-The Medicines Company
- Ceftazidime + Avibactam (CAZ-AVI)-AstraZeneca
- Cadazolid-Actelion Pharmaceuticals
- Carbavance-Rempex Pharmaceuticals (The Medicines Company)
- Delafloxacin-Melinta Therapeutics
- Eravacycline-Tetraphase Pharmaceuticals
- Plazomicin-Achaogen
- Solithromycin-Cempra Pharmaceuticals
- Surotomycin-Cubist Pharmaceuticals
Key Topics Covered:
1. Executive Summary
2. Introduction
3. Classification Of Antibacterial Drugs By Mechanism Of Action
4. Antibacterial Drugs Market-Pipeline Analysis
5. Antibacterial Drugs Market-Major Clinical Milestones
6. Antibacterial Drugs Market-Product Dashboard Of Recently Approved And Late-Stage Pipeline Drug Candidates
7. Antibiotic Resistance-A Critical Unmet Need That Poses Challenges To Antibiotic R&D
8. Antibacterial Drugs Market-Timeline Of Key Events
9. Regulatory Approaches To Stimulate Antibiotics R&D
10. Antibacterial Drugs Market-Key Companies To Watch
11. Conclusions
12. Appendix
Companies Mentioned
- Achaogen
- Actelion Pharmaceuticals
- AstraZeneca
- Cempra Pharmaceuticals
- Cubist Pharmaceuticals
- Durata Therapeutics
- Melinta Therapeutics
- Rempex Pharmaceuticals
- Tetraphase Pharmaceuticals
- The Medicines Company
For more information visit http://www.researchandmarkets.com/research/b9lrqd/a_product_and
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals,
Markets